102 / 204
Fima CORPORATION Berhad
(197401004110) (21185-P) •
Annual Report 2020
100
Directors’ benefits
Neither at the end of the financial year, nor at anytime during that year, did there subsist any arrangement to which the Company was a
party, whereby the directors might acquire benefits by means of the acquisition of shares in or debentures of the Company or any other
body corporate.
Since the end of the previous financial year, no director has received or become entitled to receive a benefit (other than a benefit included
in the aggregate amount of emoluments received or due and receivable by the directors or the fixed salary of a full-time employee of the
Company as disclosed below) by reason of a contract made by the Company or a related corporation with any director or with a firm of
which he is a member or with a company in which he has a substantial financial interest, except as disclosed in Note 35 to the financial
statements.
The directors’ remuneration of the Group and of the Company are as follows:
Group
Company
RM’000
RM’000
Directors’ remuneration
2,235
1,176
Indemnities to directors or officers
During the financial year, the directors and officers of the Group and of the Company are covered under the Directors &Officers Management
Liability Insurance (“D&O Insurance”) in respect of liabilities arising from acts committed in their respective capacity as, inter alia, the
directors and officers of the Group and of the Company subject to the terms of the D&O Insurance.
The total insured limit of D&O Insurance effected for the directors and officers of the Group and of the Company was RM20 million in any
one claim and in the aggregate for all claims (including deference costs). Expenses incurred on indemnity given or insurance effected for
any director and officer of the Group and of the Company during the financial year amounted to RM15,000.
Directors’ interests
According to the register of directors’ shareholdings, the interests of directors of the Company in office at the end of the financial year in
shares in the Company or its related corporations during the financial year were as follows:
Number of ordinary shares
As at
1 April 2019
Bought
Transferred
As at
31 March 2020
The Company
Direct interest
Rezal Zain bin Abdul Rashid
5,000
-
-
5,000
Dr. Roshayati binti Basir
167,600
-
-
167,600
Directors’
Report